logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
B

Biologics-Targets & Therapy

IF3.4
Papers11
Citations
Journal Papers 11
Publication Date
delete
Clinical Evaluation of Allergen Immunotherapy for Allergic Asthma
deleteBiologics-Targets & Therapy
IF3.4
delete2026-10-22
delete0
deleteOAAI
deleteFrancesco Catamerò; Simone Foti Randazzese; Davide Caimmi; Giovanni Paoletti; Giorgio Walter Canonica; Enrico Heffler; Andrea Giovanni Ledda; Stefano Del Giacco; Giulia Anna Maria Luigia Costanzo; Giuseppe Guida; Fabio Luigi Massimo Ricciardolo; Francesca Bertolini; Remo Poto; Rory Chan; Gilda Varricchi; Mattia Giovannini
deleteShare
deleteSave
What’s New and What’s Next for Emicizumab for the Treatment of Hemophilia A?
deleteBiologics-Targets & Therapy
IF3.4
delete2026-10-21
delete0
deleteOAAI
deleteJohnny N Mahlangu
deleteShare
deleteSave
Beyond Eczema Control: Long-Term Outcomes of Dupilumab Therapy in Six Patients with Netherton Syndrome
deleteBiologics-Targets & Therapy
IF3.4
delete2026-10-12
delete0
deleteOAAI
deleteKamila Zawadzińska-Halat; Magdalena Stec; Katarzyna Poznańska-Kurowska; Maciej Pastuszczak
deleteShare
deleteSave
Real-World Outcomes of a Non-Medical Switch to Adalimumab-Atto Biosimilar: Safety, Effectiveness, and Treatment Persistence in an Adult Saudi Tertiary Care Population
deleteBiologics-Targets & Therapy
IF3.4
delete2026-10-12
delete0
deleteOAAI
deleteAlhanouf Almousa; Mohamed Ahmed; Rayd Abdulaziz Almehizia; Meshal Aldurayhim; Gamal Mohamed; Almutairdi Abdulelah; Yousef Binamer; Ahmed Alshaikh
deleteShare
deleteSave
Apatinib Plus PD-1 Blockade versus Chemotherapy After Prior Immunotherapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Cohort Study
deleteBiologics-Targets & Therapy
IF3.4
delete2026-09-25
delete0
deleteOAAI
deleteRui-Xin Li, Hong-Wei Yang, Yun-Fei Zhang, Xin-Yu Liu
deleteShare
deleteSave
Oral Acitretin Combined with Topical 0.1% Tretinoin Cream for Facial Basal Cell Carcinoma in an Elderly Patient: A Case Report
deleteBiologics-Targets & Therapy
IF3.4
delete2026-08-14
delete0
deleteOAAI
deleteZhirong Shu; Yu Jiang; Shilin Deng; Tingnan Chen; Jingyao Liang; Xibao Zhang
deleteShare
deleteSave
Hemophagocytic Lymphohistiocytosis Triggered by HSV‑1 in a Patient with Refractory Crohn’s Disease After Long‑Term Sequential Immunosuppressive Therapy
deleteBiologics-Targets & Therapy
IF3.4
delete2026-07-30
delete0
deleteOAAI
deleteLingya Yao; Hanxiao Tu; Qian Cao
deleteShare
deleteSave
Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program
deleteBiologics-Targets & Therapy
IF3.4
delete2026-07-27
delete0
deleteOAAI
deleteRajesh Patel; Dennis Brooks; Elise Gorseth; Rachel Moate; Alexis Hofherr; Chris Kell; Gabriela Luporini Saraiva; Hitesh Pandya; Martin Jenkins; Ioannis Psallidas
deleteShare
deleteSave
Optimization of Recombinant Human Interferon-Gamma Expression and Purification in E. coli; and Developing an Immunization Protocol for the Production of Optimal Humoral Response
deleteBiologics-Targets & Therapy
IF3.4
delete2026-04-16
delete0
deleteOAAI
deleteVanessa Uwituze; Claire M Mugasa; Monica Namayanja; David Paul Nalumenya; Jerome Ndayisenga; Kenneth Ssekatawa; Charles Drago Kato
deleteShare
deleteSave
Bovine Milk Exosomes as Natural Cytoprotective Nanoplatforms Against Lead-Induced Toxicity
deleteBiologics-Targets & Therapy
IF3.4
delete2026-01-01
delete0
PREAI
deletePanda, Subhrajita; Ahmad, Faraz
deleteShare
deleteSave
Net Present Value Impact of FDA's Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
deleteBiologics-Targets & Therapy
IF3.4
delete2026-01-01
delete0
PREAI
deleteRanbhor, Ranjit; Kulkarni, Priyanka
deleteShare
deleteSave